This is a competing renewal application for T32GM007308-39, which funds the Medical Scientist Training Program (MSTP) at NYU School of Medicine (NYUSOM). The purpose of the MSTP is to train physician-scientists who will be capable of moving seamlessly between the realms of rigorous scientific inquiry and the holistic approach required for patient care. Students who successfully complete the MSTP graduate with both an MD and PhD degree. The MSTP at NYUSOM was one of the first three programs to be funded by NIGMS in 1964 and has been NIH funded ever since. Many of the 314 graduates have had illustrious careers and are counted among the leaders of academic medicine in the United States. The training begins with a summer research rotation, followed by three semesters of pre-clinical medical education punctuated by a second summer research rotation. Students then select a thesis lab and begin graduate work under the auspices of the Sackler Institute of Graduate Biomedical Sciences. Graduate training is offered in thirteen interdisciplinary training programs that include Biomedical Imaging, Biomedical Informatics, Cellular & Molecular Biology, Computational Biology, Developmental Genetics, Immunology and Inflammation, Microbiology, Molecular Biophysics, Molecular Oncology & Tumor Immunology, Molecular Pharmacology, Neuroscience & Physiology, Pathobiology, and Stem Cell Biology. Upon completion of a PhD thesis, the trainees return to medical school for the clinical portion of the curriculum, participating in all required clerkships as well as clinical electives. Trainees ar expected to complete the training in eight years or less. Over the past 5-year grant cycle, the median time-to-degree was 8.1 years. Mark Philips, MD, who runs an active molecular cell biology laboratory and who has trained 10 MSTP students, serves as the eighth director of the NYU MSTP and is assisted by two Co-Directors, Mitchell Chesler and Jennifer Philips, both MD/PhDs. A Faculty Operating Committee (FOC) and a full-time administrative staff assist the Co-directors. The training faculty consists of 121 full-time, tenure-track faculty who are selected by the Co-directors for the quality of their research programs and their skills as mentors. Admission to the NYU MSTP is highly competitive. Over the past 5-year grant cycle 1883 students applied, 517 were interviewed, 197 (10.5%) were offered admission, and 47 matriculated. Significant effort is made to enhance the diversity of MSTP students. Of the 71 students currently enrolled in the MSTP, 10 (14%) are members of underrepresented minorities, one is disabled, and three are economically disadvantaged. The competitiveness of the NYU MSTP with regard to recruiting top candidates has improved over the past 5-year grant cycle both as a consequence of reorganization of the MSTP and the sharp rise of NYUSOM in the national rankings of research medical schools (37th to 19th). The Administration of NYUSOM supports the MSTP with substantial funding: in 2013 the Administration contributed $3,967,369 (57% of the total cost). At the last competing renewal, T32GM007308-34 received an outstanding priority score and 29 training slots were funded. The government sequester in 2012 reduced the funding to 25 slots. In accord with the recent academic success of the MSTP and of NYUSOM in general, we seek to expand the MSTP from 8-10 students per year to 10-12 and therefore request funding for 35 trainees.

Public Health Relevance

This proposal seeks to renew funding for the NYU Medical Scientist Training Program (MSTP), one of 44 such programs funded by the National Institutes of Health. The dual MD/PhD degrees conferred on MSTP trainees equip them with the skills required to function both as a physician and a scientist. The MSTP thereby produces a class of professionals ideally positioned to become leaders in academic medicine and to perform rigorous, patient-oriented research designed to improve human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007308-42
Application #
9517941
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
1975-07-01
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Zhang, Xue-Song; Li, Jackie; Krautkramer, Kimberly A et al. (2018) Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity. Elife 7:
Glennon, Erin; Carcea, Ioana; Martins, Ana Raquel O et al. (2018) Locus coeruleus activation accelerates perceptual learning. Brain Res :
Handler, Jesse; Cullis, Jane; Avanzi, Antonina et al. (2018) Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-? exposure. Oncogene 37:4334-4342
Huang, Huai-Wei; Brown, Brian; Chung, Jaehoon et al. (2018) highroad Is a Carboxypetidase Induced by Retinoids to Clear Mutant Rhodopsin-1 in Drosophila Retinitis Pigmentosa Models. Cell Rep 22:1384-1391
Schneider, Jeffrey A; Logan, Susan K (2018) Revisiting the role of Wnt/?-catenin signaling in prostate cancer. Mol Cell Endocrinol 462:3-8
Wang, John; Yin, Yandong; Lau, Stephanie et al. (2018) Anosmin1 Shuttles Fgf to Facilitate Its Diffusion, Increase Its Local Concentration, and Induce Sensory Organs. Dev Cell 46:751-766.e12
Shen, Michael J; Wu, Yi; Yang, Kun et al. (2018) Heterozygous diploid and interspecies SCRaMbLEing. Nat Commun 9:1934
Mayer, Christian; Hafemeister, Christoph; Bandler, Rachel C et al. (2018) Developmental diversification of cortical inhibitory interneurons. Nature 555:457-462
Pushalkar, Smruti; Hundeyin, Mautin; Daley, Donnele et al. (2018) The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov 8:403-416
Weber, Hannah; Garabedian, Michael J (2018) The mediator complex in genomic and non-genomic signaling in cancer. Steroids 133:8-14

Showing the most recent 10 out of 265 publications